Rankings
▼
Calendar
AQST Q2 2018 Earnings — Aquestive Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
AQST
Aquestive Therapeutics, Inc.
$427M
Q2 2018 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$14M
+25.0% YoY
Gross Profit
$9M
64.3% margin
Operating Income
-$33M
-234.7% margin
Net Income
-$36M
-262.0% margin
EPS (Diluted)
$-1.52
QoQ Revenue Growth
-40.5%
Cash Flow
Operating Cash Flow
$511,000
Free Cash Flow
-$116,000
Stock-Based Comp.
$27M
Balance Sheet
Total Assets
$40M
Total Liabilities
$79M
Stockholders' Equity
-$39M
Cash & Equivalents
$11M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$14M
$11M
+25.0%
Gross Profit
$9M
$6M
+49.2%
Operating Income
-$33M
-$4M
-705.3%
Net Income
-$36M
-$6M
-518.8%
Revenue Segments
Manufacture and Supply Revenue
$9M
92%
Co-Development and Research Fees
$712,000
8%
Geographic Segments
United States
$13M
100%
← FY 2018
All Quarters
Q3 2018 →